Results 81 to 90 of about 229,492 (119)

Quantitative Analysis of Saccades in Graves\u27 Ophthalmopathy

open access: yes, 1983
N/AIn this study, thirty-one patients with mild, moderate or severe Graves\u27 ophthalmopathy were studied by quantitative infrared oculography.Diminished saccadic eye ...
Steven E. Feldon, MD
core  

Distribution of HLA DRB1*03 and TNF polymorphisms in GD patients stratified by the diagnosis of Graves’ ophthalmopathy.

open access: yes, 2013
Distribution of HLA DRB1*03 and TNF polymorphisms in GD patients stratified by the diagnosis of Graves’ ophthalmopathy.
Tomasz Bednarczuk (236555)   +10 more
core   +1 more source

Orbital Decompression in Graves’ Ophthalmopathy: Iferomedial Versus Balanced Medial Plus Lateral Wall Technique

open access: yes, 2004
Orbital Decompression in Graves’ Ophthalmopathy: Iferomedial Versus Balanced Medial Plus Lateral Wall ...
SELLARI FRANCESCHINI, STEFANO   +10 more
core  

Persistent hyperthyroidism and de novo Graves’ ophthalmopathy after total thyroidectomy

open access: yes, 2017
We report a patient with Graves’ disease who remained persistently hyperthyroid after a total thyroidectomy and also developed de novo Graves’ ophthalmopathy 5  months after surgery.
Wann Jia Loh   +3 more
core   +1 more source

An Appraisal of the Preventive Effect of Statins on the Development of Graves’ Ophthalmopathy: A Hospital-Based Cohort Study

open access: yesOphthalmology and Therapy
Introduction Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder observed in a substantial proportion of patients with Graves’ disease (GD), with debilitating symptoms of disfiguring, periorbital pain, dry eyes, diplopia, and even visual ...
Grace Chia-Yen Hsu   +4 more
doaj   +1 more source

Prevalence of Graves ophthalmopathy among patients with thyroid disease

open access: yesPhilippine Journal of Ophthalmology, 2010
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD   +2 more
doaj  

Treatment of ophthalmopathy in the course of Graves’ disease [PDF]

open access: yes, 2019
: Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Woźniak, Magdalena   +5 more
core  

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

open access: yesClinical Ophthalmology, 2012
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
McCorquodale T   +3 more
doaj  

Visual Field and Graves Ophthalmopathy

open access: yes, 2015
Whether primary or secondary to thyroid disease, Graves\u27 ophthalmopathy is surprising by its evolution despite correct treatment. Transformation to acute mode may occur very quickly.
Sabine Defoort-Dhellemmes; Jean-Philippe Woillez; Virginie Rufin
core  

High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy.

open access: yes, 1992
We have evaluated the efficacy of high-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy, and have carried out a prospective randomized clinical trial, including a single-blind evaluation, whereby 14 patients were assigned to two ...
Alberti B   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy